Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness
about
Advances in cervical screening technology.HPV for cervical cancer screening: is the era of the molecular pap smear upon us?Human papillomavirus (HPV) typing as an adjunct to cervical cancer screening.Withdrawing low risk women from cervical screening programmes. Conclusions cannot yet be drawnScreening for cervical cancer: should we test for infection with high-risk HPV?Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies.Cervical cancer screening with AMIGAS: a cost-effectiveness analysis.Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing.Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testingAn evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme.A public health approach to cervical cancer control: considerations of screening and vaccination strategies.Human papillomavirus vaccine: progress and the future.Cost-effectiveness of primarily human papillomavirus-based cervical cancer screening in settings with currently established Pap screening: a systematic review commissioned by the German Federal Ministry of Health.The cost-effectiveness of screening programs using single and multiple birth cohort simulations: a comparison using a model of cervical cancer.Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.The relationship of human papillomavirus (HPV) detection to pap smear classification of cervical-scraped cells in asymptomatic women in northeast Thailand.Will New Human Papillomavirus Diagnostics Improve Cervical Cancer Control Efforts?The HPV test in cervical screening: a brave new world?
P2860
Q30305552-451B2F84-B519-4254-88AB-AFEFE9528ECFQ30307753-BAAAB6FD-0C3E-45E2-8464-2A89893F1771Q33539325-C5073D94-6688-4B2B-B824-E9EDC2EEFD23Q33796642-A37394ED-E555-4EC7-B3ED-2CCD9E74A2D5Q33954699-A348C0E7-11B6-47B4-A37A-BCB3D92D0947Q34543338-81899ADA-B521-4080-825A-BB64C05E2F83Q36025390-7F7A4644-1F46-4A08-BF13-95181B9770A6Q36155505-3F5AAA1B-B35D-47BE-B077-E205FE9654ECQ36371450-775947F3-0FF6-4C67-B27B-A1860B875359Q36621498-6BB061FA-933E-45E4-94AF-DE2701D775B0Q36625937-AF11715E-9FB0-4538-A677-E4068BB8CC98Q36727344-7085FF62-63C1-415D-92CF-4297215F8121Q36764915-7D5B9C52-8EED-48FC-845E-8925F1F8DA51Q37133404-DF8014EF-3B7D-4B3C-93AA-187F05565C1BQ40483993-AACF4179-4F25-47A1-8154-4F5EBFB37101Q44164630-DBD0F0A5-47A3-4B75-B89F-14A30020BAAEQ44572426-379C001F-DFA7-4920-A40B-319BA4035107Q52066278-1DC07C27-B961-4F1F-98B3-A1AF97380BA6Q54333340-7D308209-DEF4-412C-BBAA-EBA9171CE3A0
P2860
Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Present evidence on the value ...... on of the (cost-)effectiveness
@ast
Present evidence on the value ...... on of the (cost-)effectiveness
@en
type
label
Present evidence on the value ...... on of the (cost-)effectiveness
@ast
Present evidence on the value ...... on of the (cost-)effectiveness
@en
prefLabel
Present evidence on the value ...... on of the (cost-)effectiveness
@ast
Present evidence on the value ...... on of the (cost-)effectiveness
@en
P2093
P2860
P356
P1476
Present evidence on the value ...... on of the (cost-)effectiveness
@en
P2093
Habbema JD
Walboomers JM
Warmerdam PG
van Ballegooijen M
van den Akker-van Marle ME
P2860
P2888
P304
P356
10.1038/BJC.1997.440
P407
P577
1997-01-01T00:00:00Z